FERRARIS, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 302
EU - Europa 163
AS - Asia 76
AF - Africa 4
SA - Sud America 4
OC - Oceania 1
Totale 550
Nazione #
US - Stati Uniti d'America 289
IT - Italia 76
IE - Irlanda 29
IN - India 18
SE - Svezia 17
CN - Cina 16
DE - Germania 12
KR - Corea 9
JP - Giappone 7
MX - Messico 7
SG - Singapore 7
TH - Thailandia 7
FI - Finlandia 6
GB - Regno Unito 6
CA - Canada 5
BR - Brasile 4
NG - Nigeria 4
NL - Olanda 4
UA - Ucraina 4
VN - Vietnam 4
BE - Belgio 3
HK - Hong Kong 3
PT - Portogallo 3
SA - Arabia Saudita 2
AU - Australia 1
CR - Costa Rica 1
DK - Danimarca 1
FR - Francia 1
GR - Grecia 1
ID - Indonesia 1
PH - Filippine 1
TW - Taiwan 1
Totale 550
Città #
Chandler 63
Dublin 29
Ashburn 26
Turin 24
Fairfield 15
Nyköping 15
Torino 12
Seattle 11
Glendale 10
Medford 10
Bangkok 7
Princeton 7
Woodbridge 7
Busan 6
Wilmington 6
Hangzhou 5
Milan 5
Ottawa 5
Abuja 4
Beijing 4
Delhi 4
Frankfurt am Main 4
Gelsenkirchen 4
Houston 4
Mumbai 4
Singapore 4
Turku 4
Bengaluru 3
Fontana 3
Gouda 3
Jacksonville 3
San Diego 3
Seoul 3
Binzen 2
Brussels 2
Cambridge 2
Catania 2
Coimbatore 2
Cuautitlán Izcalli 2
Cuneo 2
Dong Ket 2
Goiânia 2
Hong Kong 2
Jeddah 2
Mexico City 2
Naples 2
New York 2
Otemae 2
Pune 2
Settimo Torinese 2
Upper Marlboro 2
Vila Nova de Gaia 2
Washington 2
Zacatecas City 2
Ahmedabad 1
Amersfoort 1
Ann Arbor 1
Avon 1
Baltimore 1
Boston 1
Brisbane 1
Chicago 1
Chieri 1
Ebsdorfergrund 1
Falls Church 1
Garden City 1
Gravina di Catania 1
Gunzenhausen 1
Helsinki 1
Heredia 1
Huskvarna 1
Kochi 1
Krian 1
Lappeenranta 1
Lombos 1
Meta 1
Moncalieri 1
Nanjing 1
Palermo 1
Paris 1
Peer 1
Pinerolo 1
Piraeus 1
Redwood City 1
Riverton 1
Shenyang 1
Shinagawa 1
Shizuoka 1
Taipei 1
Taito 1
Trieste 1
Tuxtla Gutiérrez 1
Vittoria 1
Totale 398
Nome #
Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms 133
Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours 85
Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment 85
Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM) 66
Nanosystems in cosmetic products: A brief overview of functional, market, regulatory and safety concerns 48
Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations 47
Formulations of highly antiproliferative hydrophobic Pt(IV) complexes into lipidic nanoemulsions as delivery vehicles 32
KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease 20
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 17
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease 14
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment 13
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events 7
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma 7
Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas 2
Totale 576
Categoria #
all - tutte 2.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 2 9 11
2020/202175 5 4 9 1 7 2 2 14 12 7 2 10
2021/202279 3 0 2 9 3 2 3 4 1 6 21 25
2022/2023233 23 18 8 20 22 37 23 11 30 7 21 13
2023/2024167 17 47 7 10 15 24 5 15 1 13 13 0
Totale 576